A recombinant approach for stapled peptide discovery yields inhibitors of the RAD51 recombinase (2023)
Attributed to:
Development of an Integrated Microfluidic Platform for the Identification of Therapeutic Peptides for Unmet Medical Needs
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1039/d3sc03331g
PubMed Identifier: 38075664
Publication URI: http://europepmc.org/abstract/MED/38075664
Type: Journal Article/Review
Parent Publication: Chemical Science
Issue: 47